World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Snehal Patel Biography and Net Worth

CEO of Greenwich LifeSciences

Mr. Patel has over 30 years of experience in executive management, corporate development, operations, and investment banking in the healthcare industry. He has served as a consultant, manager, and advisor for R&D and manufacturing design, scale-up, and operations at multiple public and private biotech companies, working on clinical and pre-clinical assets in stem cell therapy, multiple sclerosis t-cell therapy, oncolytic viruses, and disposable biotech manufacturing equipment. Mr. Patel has also served as an investment banker at Sanders Morris Harris, Ferghana Partners, and JP Morgan Chase, where he focused on healthcare and biotech financing and strategic transactions. Prior to that, he worked in operations and business development at consulting firms and Bayer Corporation. He received a BS in Chemical Engineering and an MS in Biochemical Engineering from the Massachusetts Institute of Technology, a Certificate in Project Management from the University of California at Berkeley, and an MBA from the University of Chicago.

What is Snehal S. Patel's net worth?: The estimated net worth of Snehal S. Patel is at least $66.03 million as of April 1st, 2024. Mr. Patel owns 5,350,777 shares of Greenwich LifeSciences stock worth more than $66,028,588 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Patel may own. Additionally, Mr. Patel receives an annual salary of $1,010,000.00 as CEO at Greenwich LifeSciences. Learn More about Snehal S. Patel's net worth.
How old is Snehal S. Patel?: Mr. Patel is currently 61 years old. There are 4 older executives and no younger executives at Greenwich LifeSciences. Learn More on Snehal S. Patel's age.
What is Snehal S. Patel's salary?: As the CEO of Greenwich LifeSciences, Inc., Mr. Patel earns $1,010,000.00 per year. Learn More on Snehal S. Patel's salary.
How do I contact Snehal S. Patel?: The corporate mailing address for Mr. Patel and other Greenwich LifeSciences executives is , , . Greenwich LifeSciences can also be reached via phone at 832-819-3232 and via email at [email protected]. Learn More on Snehal S. Patel's contact information.
Has Snehal S. Patel been buying or selling shares of Greenwich LifeSciences?: During the past quarter, Snehal S. Patel has bought $57,240.00 of Greenwich LifeSciences stock. Most recently, on Monday, April 1st, Snehal Patel bought 3,000 shares of Greenwich LifeSciences stock. The stock was acquired at an average cost of $19.08 per share, with a total value of $57,240.00. Following the completion of the transaction, the chief executive officer now directly owns 5,350,777 shares of the company's stock, valued at $102,092,825.16. Learn More on Snehal S. Patel's trading history.
Who are Greenwich LifeSciences' active insiders?: Greenwich LifeSciences' insider roster includes Frank Daugherty (Insider), Kenneth Hallock (Director), David McWilliams (Director), Snehal Patel (CEO), and Jaye Thompson (VP). Learn More on Greenwich LifeSciences' active insiders.
Are insiders buying or selling shares of Greenwich LifeSciences?: During the last year, Greenwich LifeSciences insiders bought shares 21 times. They purchased a total of 53,400 shares worth more than $604,290.50. The most recent insider tranaction occured on April, 1st when CEO Snehal Patel bought 3,000 shares worth more than $57,240.00. Insiders at Greenwich LifeSciences own 52.9% of the company. Learn More about insider trades at Greenwich LifeSciences.
Information on this page was last updated on 4/1/2024.

Snehal S. Patel Insider Trading History at Greenwich LifeSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Buy	3,000	$19.08	$57,240.00	5,350,777
3/22/2024	Buy	2,500	$19.98	$49,950.00	5,347,777
3/20/2024	Buy	1,500	$17.68	$26,520.00	5,345,277
3/4/2024	Buy	4,100	$13.03	$53,423.00	5,340,277
2/15/2024	Buy	12,700	$11.07	$140,589.00	5,325,377
11/10/2023	Buy	5,000	$10.17	$50,850.00	5,312,677
11/3/2023	Buy	3,500	$9.11	$31,885.00	5,307,677
10/25/2023	Buy	2,500	$7.91	$19,775.00	5,301,677
10/10/2023	Buy	1,000	$9.07	$9,070.00	5,299,177
10/4/2023	Buy	2,000	$8.63	$17,260.00	5,298,177
9/19/2023	Buy	4,000	$8.95	$35,800.00	5,296,177
9/19/2023	Buy	4,000	$8.95	$35,800.00	5,296,177
9/11/2023	Buy	1,000	$9.48	$9,480.00	5,292,177
8/22/2023	Buy	1,000	$9.97	$9,970.00	5,291,177
8/4/2023	Buy	2,000	$10.55	$21,100.00	5,290,177
7/21/2023	Buy	1,000	$9.20	$9,200.00	5,288,177
5/17/2023	Buy	1,000	$11.69	$11,690.00	5,287,177
4/18/2023	Buy	2,000	$11.12	$22,240.00	5,279,177
4/11/2023	Buy	5,000	$12.42	$62,100.00	5,271,177
3/10/2023	Buy	1,000	$12.12	$12,120.00	2,737,486
2/17/2023	Buy	600	$16.53	$9,918.00	2,736,486
2/10/2023	Buy	1,000	$18.68	$18,680.00	2,735,886
1/27/2023	Buy	2,000	$19.35	$38,700.00	2,734,886
1/20/2023	Buy	1,500	$17.37	$26,055.00	2,732,886
1/6/2023	Buy	1,500	$15.18	$22,770.00	2,731,386
12/16/2022	Buy	1,000	$13.01	$13,010.00	2,725,886
12/9/2022	Buy	2,000	$13.11	$26,220.00	2,724,886
12/2/2022	Buy	1,000	$13.84	$13,840.00	2,722,886
11/2/2022	Buy	2,000	$8.79	$17,580.00	2,721,886
10/14/2022	Buy	3,000	$9.75	$29,250.00	2,719,886
10/7/2022	Buy	2,000	$9.72	$19,440.00	2,716,886
10/7/2022	Buy	2,000	$9.72	$19,440.00	2,716,886
9/29/2022	Buy	1,000	$9.23	$9,230.00	2,713,886
6/24/2022	Buy	22,535	$9.13	$205,744.55	2,706,421
6/16/2022	Buy	8,000	$7.13	$57,040.00	2,683,886
6/14/2022	Buy	12,000	$7.91	$94,920.00	2,675,886
6/9/2022	Buy	4,500	$10.90	$49,050.00	1,243,453
6/7/2022	Buy	6,000	$8.55	$51,300.00	1,238,953
6/2/2022	Buy	6,774	$7.38	$49,992.12	1,223,703
4/21/2022	Buy	6,000	$16.09	$96,540.00	1,216,929
4/19/2022	Buy	6,000	$16.74	$100,440.00	1,210,929
2/11/2022	Buy	5,500	$19.80	$108,900.00
2/4/2022	Buy	5,000	$19.59	$97,950.00
1/3/2022	Buy	2,050	$23.82	$48,831.00
12/14/2021	Buy	1,840	$27.17	$49,992.80
4/13/2021	Buy	2,700	$36.98	$99,846.00	1,189,539
11/19/2020	Buy	2,000	$5.40	$10,800.00	1,186,839

Snehal S. Patel Buying and Selling Activity at Greenwich LifeSciences

Greenwich LifeSciences Company Overview

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Today's Range

Now: $12.34

$12.05

$12.91

50 Day Range

MA: $15.50

$11.24

$20.32

2 Week Range

Now: $12.34

$7.58

$21.44

Volume

30,894 shs

Average Volume

45,534 shs

Market Capitalization

$158.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Click here to find out what to do.

Snehal Patel Biography and Net Worth

What is Snehal S. Patel's net worth?

How old is Snehal S. Patel?

What is Snehal S. Patel's salary?

How do I contact Snehal S. Patel?

Has Snehal S. Patel been buying or selling shares of Greenwich LifeSciences?

Who are Greenwich LifeSciences' active insiders?

Are insiders buying or selling shares of Greenwich LifeSciences?